Aevus Precision Diagnostics
THE FUTURE
OF MEDICINE

Healthcare professionals are just beginning to recognize the potential of utilizing and analyzing a patient's genetic profile.

Many are uncovering breakthroughs in the lab, but for one talented entrepreneur, brilliance came while taking his dog, Zoe, to the vet.

Cameron Owen was in the office, waiting for the doctor to prescribe medication. But first the doctor ran a genetic test to determine if she would be a good candidate for the drugs.

This is when Owen had his "aha!" moment.

He quickly saw the potential of using a patient's unique genetic profile to help steer them towards tailored therapeutics.

He also realized that this was how the promise of precision medicine would be realized.

He then founded Aevus Precision Diagnostics to make this a reality.

Aevus Precision Diagnostics
MAJOR COMPLICATIONS

Type 2 Diabetes (T2D) costs the healthcare system 
$245 billion every year.

Part of this is due to the emergency care and hospitalization that follows adverse drug reactions (ADRs).

The cost of ADRs totaled more than $30 billion in 2013 due to increased hospitalization.

It also led to greater suffering among a countless number of patients.

Aevus Precision Diagnostics
BRILLIANT
SOLUTION 

Aevus Precisions Diagnostics has developed a test, GeneLead, to help to personalize medicine for patients with Type 2 Diabetes.

We accomplish this by helping healthcare professionals tailor pharmaceuticals to an individual's genetic profile.

As a result, Aevus solves the problem of adverse drug reactions, which cause nearly 10% of hospitalizations.

We are proudly empowering physicians with the diagnostics powers of pharmacogenomics.

Aevus Precision Diagnostics
HOW
WE DO IT

Aevus Precision Diagnostics
HOW IT
WORKS

Aevus Precision Diagnostics
MEET THE
TEAM 

Cameron Owen | CEO and Co-Founder

• Experienced in the startup space with a passion for genetics, stemming from his background in Microbiology
• While completing a Masters in Healthcare Management from Carey Business School and working as a student Advisor to the NIH’s Office of Technology Transfer, Owen began working on the launch of Aevus
• The company was a finalist and won the “Most Original Idea” award at the Johns Hopkins Business Plan Competition

Ian Moore | CTO

• Software engineer with broad experience developing solutions for:
• Finance
• Insurance
• Management consulting
• Marketing
• Academic research
• Has spent his time in the industry working with and leading teams to create both public-facing products and mission-critical IT systems
• His projects have enabled companies to streamline operations, enhance product offerings, and utilize cloud infrastructure

Yash Sagar Santani | CFO

• Santani is a keen corporate valuations and software technology enthusiast
• He possesses a well-rounded academic and professional experience in multiple international locations
• A recent MS in Finance graduate from the Johns Hopkins University, Santani is adept at:
• Quantitative modeling
• Valuations
• Due diligence
• Software scripting
• Creative writing
• Delivering compelling presentations that inspire action
• B.S. in Computer Technology from Purdue University